DURECT Corporation · Cupertino, CA United States (NASDAQ: DRRX)
| 2 Results Way | Phone: 408-777-1417 |
| Cupertino, CA | Fax: 408-777-3577 |
| 95014 | |
| United States | 
Map This Company |
DURECT Corporation Rankings
| Russell 2000 (June 2011) |
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
DURECT wants your medicine to go DURECTly where it's needed. The company is developing drug delivery systems to provide long-term therapy for such conditions as chronic pain, heart disease, cancer, and neurological disorders. Drug delivery technologies provided by DURECT include SABER, a controlled-release injectable; TRANSDUR, a transdermal patch; ORADUR, a sustained release oral gel-cap; DUROS, an osmotic implant; and DURIN, a biodegradable implant. Its R&D efforts are conducted independently and collaboratively. DURECT also sells two commercial products -- biodegradable polymers (Lactel) and osmotic pumps (ALZET) -- to pharmaceutical and medical research firms.
DURECT Corporation Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: DRRX Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 106 |
Executives
24 executives listed for DURECT Corporation's Cupertino, CA location.
| Chairman and Chief Scientific Officer | Felix Theeuwes | |
|---|---|---|
| President, CEO, and Director | James Brown | |
| EVP Operations and Administration | Paula Mendenhall |